AQR Arbitrage’s Intelligent Medicine Acquisition Corp. Class A Common Stock IQMD Stock Holding History

AQR Arbitrage’s Portfolio IQMD Stock Details IQMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-566,827	Closed	-$5.83M	–	1141
2022 Q4	$5.83M	Buy	566,827 +13,455	+2%	+$137K	0.15%	199
2022 Q3	$5.57M	Buy	553,372 +98,282	+22%	+$987K	0.12%	225
2022 Q2	$4.56M	Buy	455,090 +169,000	+59%	+$1.69M	0.1%	265
2022 Q1	$2.86M	Buy	+286,090	New	+$2.84M	0.07%	306

Other funds holding IQMD

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return

Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return

Walleye Trading New York $60B AUM 42.19% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return

Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Allworth Financial Folsom, California $24.7B AUM 15.55% 1-Year Est. Return

AQR Arbitrage's IQMD Position: Q1 2023 in Review

AQR Arbitrage sold out of Intelligent Medicine Acquisition Corp. Class A Common Stock (IQMD) in Q1 2023, closing a stake of 566,827 shares — an estimated $5.83M sold.

AQR Arbitrage first reported a position in IQMD in Q1 2022 and held it in 4 quarters. The position peaked at $5.83M in Q4 2022. 8 funds tracked by Wall St. Rank hold IQMD as of Q1 2023.

AQR Arbitrage reported no remaining Intelligent Medicine Acquisition Corp. Class A Common Stock position as of Q1 2023 after selling out during the quarter.
AQR Arbitrage sold 566,827 Intelligent Medicine Acquisition Corp. Class A Common Stock shares in Q1 2023, an estimated $5.83M.
AQR Arbitrage first reported a position in Intelligent Medicine Acquisition Corp. Class A Common Stock in Q1 2022 and held it in 4 quarters.
AQR Arbitrage's Intelligent Medicine Acquisition Corp. Class A Common Stock position peaked at $5.83M in Q4 2022.
8 funds tracked by Wall St. Rank held Intelligent Medicine Acquisition Corp. Class A Common Stock as of Q1 2023.

Based on AQR Arbitrage's 13F filing for Q1 2023, filed 15 May 2023.